Positive Phase 1 Results: Vaxxinity’s UB-312 Shows Promise in Parkinson’s Disease
By Daniella Parra Vaxxinity (Nasdaq: VAXX) has revealed encouraging findings from the Phase 1b clinical...
By Daniella Parra Vaxxinity (Nasdaq: VAXX) has revealed encouraging findings from the Phase 1b clinical...
By Daniella Parra HistoIndex will present advancements in AI-powered stain-free tissue imaging for NASH clinical...
By Daniella Parra Swiss life sciences company Lunaphore presented data on the capabilities of its COMET...
By Daniella Parra The Duckhorn Portfolio, Inc. (NYSE: NAPA) reported its financial results for the...
By Daniella Parra AvePoint (Nasdaq: AVPT) said it is partnering with Microsoft Syntex repository services...
By Daniella Parra Octave announced new data at the Consortium of Multiple Sclerosis Centers (CMSC)...
By Daniella Parra Global fashion luxury group Capri Holdings Limited (NYSE:CPRI) said it had record...
By Daniella Parra TH International Limited (Nasdaq: THCH), the exclusive operator of Tim Hortons coffee...
By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) announced a study that demonstrated that its oral...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it named Megan Yung as Chief...